Finance

Lists
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
558,10 INR
-0,64%
(-3,60) 1D
9 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
558,00 INR
High
574,95 INR
Low
553,60 INR
Mkt. cap
11,14 მლრდ.
Avg. vol.
32,17 ათ.
Volume
19,35 ათ.
Dividend
0,32%
Quarterly dividend
0,45 INR
Ex-dividend date
11 სექ. 2026
P/E ratio
11,59
52-wk high
770,00 INR
52-wk low
440,00 INR
EPS
48,16 INR
Shares outstanding
20,00 მლნ.
No. of employees
1 ათ.
Open
558,00 INR
High
574,95 INR
Low
553,60 INR
Mkt. cap
11,14 მლრდ.
Avg. vol.
32,17 ათ.
Volume
19,35 ათ.
Dividend
0,32%
Quarterly dividend
0,45 INR
Ex-dividend date
11 სექ. 2026
P/E ratio
11,59
52-wk high
770,00 INR
52-wk low
440,00 INR
EPS
48,16 INR
Shares outstanding
20,00 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
6 საათის წინ
S&P 500: The Quick And Easy Days Are Over (SP500)
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1,35 ათ.
Founded1979
Headquarters-
SectorPharmaceutical industry
Last report
13 აგვ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,77 მლრდ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,63 მლრდ.
1,66 მლრდ.
1,87 მლრდ.
1,77 მლრდ.
Cost of goods sold
767,46 მლნ.
759,60 მლნ.
967,33 მლნ.
851,43 მლნ.
Cost of revenue
767,46 მლნ.
759,60 მლნ.
967,33 მლნ.
851,43 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
303,56 მლნ.
306,18 მლნ.
389,12 მლნ.
333,10 მლნ.
Operating expense
648,09 მლნ.
704,87 მლნ.
684,68 მლნ.
685,91 მლნ.
Total operating expenses
1,42 მლრდ.
1,46 მლრდ.
1,65 მლრდ.
1,54 მლრდ.
Operating income
218,09 მლნ.
198,75 მლნ.
220,76 მლნ.
235,48 მლნ.
Other non operating income
72,32 მლნ.
151,46 მლნ.
-379,32 მლნ.
242,65 მლნ.
EBT including unusual items
288,11 მლნ.
347,22 მლნ.
167,03 მლნ.
475,54 მლნ.
EBT excluding unusual items
288,11 მლნ.
347,22 მლნ.
146,26 მლნ.
475,54 მლნ.
Income tax expense
88,27 მლნ.
61,22 მლნ.
50,68 მლნ.
113,19 მლნ.
Effective tax rate
30,64%
17,63%
30,34%
23,80%
Other operating expenses
308,34 მლნ.
361,49 მლნ.
258,73 მლნ.
313,96 მლნ.
Net income
199,84 მლნ.
286,00 მლნ.
116,35 მლნ.
362,34 მლნ.
Net profit margin
12,23%
17,20%
6,21%
20,44%
Earnings per share
-
-
-
-
Interest and investment income
-
-
82,21 მლნ.
-
Interest expense
-2,31 მლნ.
-2,98 მლნ.
-
-2,59 მლნ.
Net interest expenses
-2,31 მლნ.
-2,98 მლნ.
82,21 მლნ.
-2,59 მლნ.
Depreciation and amortization charges
36,19 მლნ.
37,21 მლნ.
36,83 მლნ.
38,84 მლნ.
EBITDA
253,58 მლნ.
230,69 მლნ.
256,62 მლნ.
271,73 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები